You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-Cll

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

Active, not recruiting
  • Chronic Lymphocytic Leukemia
    • Manhasset, New York
      Feinstein Institute for Medical research
    Jul 6, 2022

    Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • +3 more
    • Ibrutinib 420 mg
    • (no location specified)
    Jan 12, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Questionnaires
    • Fit Bit
    • Houston, Texas
      M D Anderson Cancer Center
    May 18, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Observation
    • (no location specified)
    Oct 12, 2023

    CLL, SLL, HCL Trial in Dresden

    Recruiting
    • CLL
    • +7 more
      • Dresden, Sachsen, Germany
        BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
      Apr 29, 2022

      B-cell NHL, CLL Trial (CARCIK-CD19)

      Not yet recruiting
      • B-cell NHL
      • CLL
      • CARCIK-CD19
      • (no location specified)
      May 19, 2023

      Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

      Completed
      Has Results
      • Hepatitis
      • Safety and Tolerability
      • HEPLISAV-B
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 13, 2022

      Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

      Completed
      • Leukemia, Chronic Lymphatic
      • Stuttgart, Baden-Wuerttemberg, Germany
      • +4 more
      Nov 24, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

      Enrolling by invitation
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma (SLL)
      • 5:2 Method (intermittent fasting regimen)
      • 16/8 Method (intermittent fast regimen)
      • Victoria, British Columbia, Canada
        Eleah Stringer
      Feb 2, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • TQB3909 tablet
      • Zhengzhou, Henan, China
      • +1 more
      Jul 17, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Acalabrutinib (Arm A)
      • Acalabrutinib (Arm B)
      • Bethesda, Maryland
        Research Site
      Jan 3, 2023

      Chronic Lymphocytic Leukemia Trial in Russian Federation

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Irkutsk, Russian Federation
        • +5 more
        Jan 17, 2023

        B Cell NHL, CLL Trial in Sydney, Melbourne, Mount Pleasant (GB261)

        Recruiting
        • B Cell NHL
        • CLL
        • GB261
        • Sydney, New South Wales, Australia
        • +4 more
        Nov 16, 2022

        Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

        Not yet recruiting
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • Zanubrutinib Pill
        • +2 more
        • New York, New York
          Weill Cornell Medicine/NewYork-Presberteryian Hospital
        Dec 6, 2022

        Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

        Not yet recruiting
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • +5 more
        • (no location specified)
        Jul 21, 2023

        Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

        Active, not recruiting
        • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
        • +2 more
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Jan 20, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Dec 5, 2022

        Retention Rate of Acalabrutinib in a Non-interventional Setting

        Recruiting
        • Chronic Lymphocytic Leukaemia (CLL)
          • Zittau, Germany
            Research Site
          Jan 12, 2023

          Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

          Completed
          Has Results
          • Non-Hodgkin's Lymphoma, Relapsed
          • +8 more
          • PBCAR20A
          • +2 more
          • Duarte, California
          • +4 more
          Jan 4, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

          Active, not recruiting
          • Chronic Lymphocytic Leukemia
          • +3 more
          • Boston, Massachusetts
            Dana Farber Cancer Institute
          Dec 19, 2022

          Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

          Terminated
          Has Results
          • Chronic Lymphocytic Leukemia(CLL)
          • Small Lymphocytic Lymphoma
          • Hackensack, New Jersey
            Hackensack University Medical Center
          Jun 24, 2022

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

          Active, not recruiting
          Has Results
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • High Dose Methylprednisolone (HDMP)
          • +2 more
          • Tampa, Florida
            H. Lee Moffitt Cancer Center and Research Institute
          Jan 12, 2023

          Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

          Completed
          • Chronic Lymphocytic Leukemia (CLL)
          • Waldenstrom Macroglobulinemia (WM)
          • Shingrix vaccine
          • Rochester, New York
            University of Rochester
          Jan 9, 2023